Rolfes, Leoni et al "Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19." Neurology - Neuroimmunology Neuroinflammation 8.5 (2021): e1035. Web. 08 June. 2023.

Citation Manager Formats